324 related articles for article (PubMed ID: 24750361)
21. Systemic inflammation and metabolic syndrome in stable COPD patients.
Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
[TBL] [Abstract][Full Text] [Related]
22. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
Yu J; Han J; Mao J; Guo L; Gao W
Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
[TBL] [Abstract][Full Text] [Related]
23. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
24. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
[TBL] [Abstract][Full Text] [Related]
25. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study.
Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A
Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368
[TBL] [Abstract][Full Text] [Related]
26. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
Wang SL; Han YL; Liu LJ; Yan CH; Kang J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
[TBL] [Abstract][Full Text] [Related]
27. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
[TBL] [Abstract][Full Text] [Related]
28. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
[TBL] [Abstract][Full Text] [Related]
29. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
31. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
32. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
35. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
36. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
38. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention.
Shimizu T; Suwa S; Dohi T; Wada H; Miyauchi K; Shitara J; Endo H; Doi S; Ogita M; Kasai T; Okazaki S; Isoda K; Daida H
Int Heart J; 2019 Sep; 60(5):1037-1042. PubMed ID: 31484863
[TBL] [Abstract][Full Text] [Related]
40. Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Zhang M; Cheng YJ; Zheng WP; Liu GH; Chen HS; Ning Y; Zhao X; Su LX; Liu LJ
Biomed Res Int; 2016; 2016():8212459. PubMed ID: 28042573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
